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Aurilide is a potent cytotoxic marine natural product
that induces apoptosis in cultured human cells at
the picomolar to nanomolar range; however, its
mechanism of action has been unknown. Results of
the present study showed that aurilide selectively
binds to prohibitin 1 (PHB1) in the mitochondria,
activating the proteolytic processing of optic atrophy
1 (OPA1) and resulting in mitochondria-induced
apoptosis. The mechanism of aurilide cytotoxicity
suggests that PHB1 is an apoptosis-regulating pro-
tein amenable to modulation by small molecules.
Aurilide may serve as a small-molecule tool for
studies of mitochondria-induced apoptosis.
INTRODUCTION
Naturally occurring small molecules are an important source of
both drug leads and cell biology tools. Natural products are
particularly valuable as research tools, because they are often
coevolved with protein targets and, therefore, are likely to exhibit
high selectivity to the human counterparts of those targets.
Determination of the molecular targets of natural products has
had profound effects on studies of complex cellular machinery.
Such natural products include colchicine in the cytoskelton
research (Weisenberg et al., 1968), FK506 in immune responses
(Harding et al., 1989; Liu et al., 1991), rapamycin in nutrient
signaling (Brown et al., 1994), fumagillin in angiogenesis
research (Sin et al., 1997), phorbol diesters in the study of a family
of protein kinases (Blumberg, 1981), trapoxin B and trichostatin
A in chromatin remodeling (Laherty et al., 1997; Taunton et al.,
1996; Yoshida et al., 1990), leptomycin B in nuclear trafficking
(Fornerod et al., 1997; Fukuda et al., 1997; Ossareh-Nazari
et al., 1997), capsaisin in nociceptive signal transduction (Ca-
terina et al., 1997), and lactacystin in proteasome studies (Fen-
teany et al., 1995). Thus, despite the difficulties involved in
isolating and synthesizing natural products, successful identifi-
cation of their targets is likely to stimulate research in basic cell
biology and biomedicine.Chemistry & Biology 18, 131Here we report isolation of a protein target of aurilide (Figure 1,
structure 1), a potent cytotoxic marine natural product. The
gross structure of this cyclic depsipeptidewas initially elucidated
through spectroscopic analysis of 0.5 mg of the molecule iso-
lated from 262 kg of the Japanese seahare, Dolabella auricularia
(Suenaga et al., 1996), and the absolute stereostructure was
subsequently confirmed by enantioselective total synthesis
(Mutou et al., 1997; Suenaga et al., 2004). The ability of aurilide
to induce apoptosis in human cancer cells at low concentrations
has encouraged biological analyses (Suenaga et al., 2004) and
synthetic studies (Takahashi et al., 2003). However, its mecha-
nism of action has remained unknown.
To identify the target of this potent cytotoxic molecule, we
biochemically isolated a selective aurilide-binding protein, pro-
hibitin 1 (PHB1). Our mechanistic analyses indicate that the
interaction of aurilide with PHB1 in mitochondria activates the
proteolytic processing of optic atrophy 1 (OPA1), leading tomito-
chondrial fragmentation and apoptosis. Our results suggest that
PHB1 plays a pivotal role in maintaining mitochondrial integrity
and cell survival.RESULTS AND DISCUSSION
To isolate the protein target(s) of aurilide, we prepared its affinity
matrix. Structure-activity relationship studies have shown that
modifications at the C35 hydroxyl group had a limited impact
on the biological activity of aurilide (Suenaga et al., 2008). The
hydroxyl group was conjugated with a biotin molecule through
a protease-cleavable polyproline linker, an extended linker we
recently developed to boost biochemical purification of target
proteins (Sato et al., 2007). The resulting molecule (3) was bound
to avidin beads, which were treated with nuclear, cytosolic, and
membrane extracts of HeLa cells. Bound proteins were eluted
with HRV-3C protease. The sample treated with membrane
extracts exhibited a 30-kDa protein band selective to the beads
with aurilide, but not to the beads with 6-epi-aurilide (Figure 1B),
a >1000-fold less active epimer of aurilide (Suenaga et al., 2004)
(Figure 1A, molecule 2 and conjugate 4). Microsequencing anal-
ysis of the band showed 12 tryptic peptide sequences, all of
which matched the amino-acid sequence of human prohibitin 1
(PHB1) (see Figure S2 available online). We also noticed a–139, January 28, 2011 ª2011 Elsevier Ltd All rights reserved 131
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Figure 1. Isolation of Prohibitin 1 as an Aurilide-
Binding Protein
(A) Structures of aurilide derivatives 1–4. A recognition
sequence of HRV-C3 protease is shown in italics.
(B) Isolation of PHB1 by a biotinylated proline-rod aurilide
(3). Conjugates 3 and 4 were bound to avidin beads, and
each sample was incubated with membrane cell extracts.
Bound proteins were separated on an SDS gel and visual-
ized by silver staining. The results of isolation from nuclear
and cytosolic extracts are shown in Figure S1.
(C) Direct association of aurilide with PHB1. Conjugates 3
and 4 were bound to avidin beads, and each sample was
incubated with recombinant, bacterially expressed GST-
PHB1 or GST-PHB2. After extensive wash, bound proteins
were separated by an SDS gel and visualized by silver
staining. It was evident that GST-PHB1 bound to the
beads with aurilide but not to the beads with 6-epi-aurilide.
GST-PHB2 had no detectable affinity to the beads either
with aurilide or 6-epi-aurilide.
See also Figures S1, S2, and S11.
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The Mechanism of Aurilide-Induced Cell Deathseemingly selective weaker band with a lower molecular weight
on the SDS gel. Microsequencing analysis of these minor bands
showed that the bands consist of amixture of abundant proteins:
only one or two tryptic peptide sequences were identified for
each protein. In our experience of biochemical target isolation
using a protease-cleavable polyproline linker, we had never iso-
lated PHB1 either with empty beads, beads with the polyproline
linker, or beads with bioactive molecules. We therefore decided
to focus our efforts on PHB1 for further investigation.
Recombinant, bacterially expressed GST-PHB1 bound to the
beads with aurilide, but not to the beads with 6-epi-aurilide (Fig-
ure 1C). We also examined whether aurilide binds to PHB2,
a closely related protein that forms a heterodimer with PHB1
(Tatsuta et al., 2005). Aurilide or 6-epi-aurilide had no detectable
affinity to bacterially expressed GST-PHB2 (Figure 1C). These
results indicate that aurilide binds selectively and directly to
PHB1.
PHB1 has been identified as a putative negative regulator of
cell proliferation (Nuell et al., 1991) and is highly conserved in
all animal species, as well as in yeasts and plants (Loukas and132 Chemistry & Biology 18, 131–139, January 28, 2011 ª2011 Elsevier Ltd All rightsMaizels, 1998; McClung et al., 1992; Snedden
and Fromm, 1997). PHB1 localizes in the inner
membrane of the mitochondria, where it is com-
plexed with PHB2. Although a number of poten-
tial functions have been proposed for PHB1
(Nijtmans et al., 2000; Rastogi et al., 2006a,
2006b; Snyder et al., 2005), its precise cellular
function has been elusive.
To evaluate the involvement of PHB1 in auri-
lide-induced cell death, we examined the effects
of overexpression and siRNA knockdown of
PHB1 on the sensitivity of cells to aurilide. For
overexpression, PHB1 cDNA was stably trans-
fected into HeLa cells, and the resulting three
stable cell lines that overexpressed PHB1 at
different levels were analyzed. The cells with
higher levels of PHB1 were more resistant to
aurilide than were the parental cells (Figure 2A).For siRNA knockdown, three stable cell lines with lower PHB1
levels were similarly prepared. Partial knockdown of PHB1
apparently rendered cells viable, permitting establishment of
cell lines. The cells in which PHB1 was partially knocked down
were more sensitive to aurilide (Figure 2B). In these experiments,
we also checked the protein levels of endogenous PHB2, which
forms a heterodimer with PHB1. The results showed that PHB2
expression was up- or down-regulated when PHB1 was overex-
pressed or knocked down, respectively (Figure S3). The depen-
dence of aurilide sensitivity on the expression levels of PHBs
suggests that aurilide exerts its cytotoxicity by inhibiting a func-
tion of the PHB complex.
It has been reported that complete silencing of PHB1 causes
morphological alteration of mitochondria from tubular to frag-
mented forms, followed by mitochondria-induced cell death
(Kasashima et al., 2006). In fact, we were able to reproduce
the mitochondrial phenotype in our hands when the PHB1
expression was silenced by transiently transfecting its siRNA
(Figure S4). If aurilide is an inhibitor of PHB1, treatment with auri-
lide should produce a phenotype similar to that of the siRNAreserved
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Figure 2. Effects of PHB1 Overexpression and
Knockdown on Aurilide Sensitivity
(A) Effects of PHB1 overexpression in HeLa cells. Three
stable cell lines that overexpress PHB1 at different levels
were used (I, II, and III). HeLa cells were treated with
6 nM of aurilide. The expression levels of PHB1 in each
cell line were estimated by western blot analysis (middle
panel) and quantified by densitometric analysis (lower
panel).
(B) Effects of PHB1 knockdown on aurilide sensitivity in
HeLa cells. Three stable cell lines in which PHB1 is
knocked down at different levels were used (I, II, and III).
HeLa cells were treated with 3 nM of aurilide. The expres-
sion levels of endogenous PHB1 were analyzed by
western blots with an antibody against human PHB1
(upper panel). Approximately 60% knockdown of PHB1
was observed in siRNA-transfected cells (lower panel).
The data are means ± SD for a minimum of three experi-
ments. Different concentrations of aurilide were used in
overexpression (6 nM) and knockdown (3 nM) experiments
because of the lower sensitivity of PHB1-overexpressiong
cell lines to aurilide.
See also Figure S3.
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The Mechanism of Aurilide-Induced Cell Deathknockdown. As predicted, HeLa cells treated with aurilide and
then stained with MitoTracker Red exhibited fragmented mito-
chondria, whereas DMSO-treated control cells had tubular
mitochondria without morphological alterations (Figure 3A).
The mitochondrial fragmentation was also confirmed in the cells
transfected with a gene encoding RFP-mito, a mitochondrial
targeted red fluorescent protein (Figure S5). The inactive epimer
of aurilide, 6-epi-aurilide, failed to induce mitochondrial frag-
mentation (data not shown). Mitochondrial fragmentation was
evidently not a result of apoptotic cell death, because fragmen-
tation occurred prior to the appearance of apoptotic pheno-
types, including condensed nuclei, round cell shapes (Figure 4A),
caspase 3–mediated processing of poly (ADP-ribose) poly-
merase (Figure 4B), loss of membrane potential (Figure 4C; Fig-
ure S6), phosphatidylserine detection (Annexin V-FACS experi-
ment) (Figure S7), and cytochrome c release (Figure S8), all of
which were observed 16 hr after aurilide treatment.
To further confirm that aurilide selectively targets PHB1 in
mitochondria, we examined the subcellular localization of auri-
lide-fluorescein conjugate 5 (Figure 3C). When HeLa cells were
treated with this conjugate, intense fluorescence signals were
observed in mitochondria undergoing fragmentation (Figure 3D).
In contrast, cells treated with 6-epi-aurilide-fluorescein conju-
gate 6 showed neither clear fluorescent accumulation nor
morphological changes in the mitochondria (Figure 3D; Fig-
ure S9). These results supported the hypothesis that aurilide
induces mitochondrial fragmentation by binding to PHB1 in the
mitochondria.
Mitochondria constantly fuse and divide, and an imbalance of
these two processes dramatically alters overall mitochondrial
morphology. The disruption of fission generates the excessively
elongated filaments in the perinuclear space (Smirnova et al.,
2001; Yoon et al., 2003). In contrast, the disruption of fusion
causes the morphological change from tubular to fragmented
mitochondria (Detmer and Chan, 2007; Suen et al., 2008). TheChemistry & Biology 18, 131proteins essential to the fusion process are mitofusins (Mfns)
and optic atrophy 1 (OPA1), both of which work together to
achieve controlled mitochondrial fusion (Chen et al., 2005; Cipo-
lat et al., 2004; Griparic et al., 2004). Mfns are outer membrane
proteins that induce mitochondrion-mitochondrion contacts
through dimerization. The dimerization of Mfns is controlled by
OPA1, a dynamin-like GTPase anchored on the inner membrane
of mitochondria. Human OPA1 exists as eight transcript variants
encoding different isoforms, each of which is proteolytically
processed to yield two isoforms with different chain lengths:
the long (L) isoform and the short (S) isoform. The L-isoforms
activate mitochondrial fusion by interacting with Mfns; the S-iso-
forms arrest fusion and generate mitochondrial fragments
(Duvezin-Caubet et al., 2006, 2007; Ishihara et al., 2006).
To determine the mechanism by which aurilide induces mito-
chondrial fragmentation, we investigated the effects of aurilide
on OPA1 and Mfn, as well as on PHB1 and PHB2. Western
blot analyses showed that aurilide treatment decreased the
size of OPA1 bands on the SDS gel, whereas no detectable
changes were observed in the Mfn, PHB1, PHB2, and actin
bands (Figure 5A). Note that endogenous OPA1 proteins are
usually detected as multiple bands in western blot analyses,
because of the eight different transcript variants and their L-
and S-isoforms (Ishihara et al., 2006). Aurilide treatment of cells
caused these bands to converge into the faster migrating bands
that correspond to S-isoforms of OPA1. The inactive epimer of
aurilide, 6-epi-aurilide, failed to induce such a band shift (data
not shown). These results suggest that aurilide accelerates the
proteolytic processing of OPA1 L-isoforms to S-isoforms.
To further examine the role of theOPA1 processing in the cyto-
toxic activity of aurilide, we prepared a stable HeLa cell line that
expresses the deletion mutant of OPA1 in which an 11–amino
acid processing site is deleted (variant1-DS1) (Ishihara et al.,
2006). The overexpression of the proteolysis-resistant mutant
rendered the cells more resistant to aurilide than neo cells and–139, January 28, 2011 ª2011 Elsevier Ltd All rights reserved 133
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Figure 3. Effects of Aurilide on Mitochondria
(A) Effects of treatment with aurilide on mitochondrial
morphology in HeLa cells. Treatment with 100 nM aurilide
induced mitochondrial fragmentation (left panel); treat-
ment with DMSO showed tubular mitochondria with no
morphological change (right panel). Mitochondria were
stained by MitoTracker Red.
(B) Quantification of mitochondrial fragmentation in HeLa
cells treated with aurilide (100 nM) or DMSO alone (1%
[v/v]). The numbers of tubular (white bars) or fragmented
(gray bars) mitochondria were counted.
(C) Chemical structures of aurilide-FITC and 6-epi-aurilide-
FITC conjugates (5, 6).
(D) Subcellular localization of conjugate 5 in HeLa cells.
Mitochondria were visualized with MitoTracker. Conjugate
5 (green) and MitoTracker (red) were colocalized. In these
experiments, the relatively high concentration (100 nM) of
aurilide was used for the observation of clear morpholog-
ical images.
See also Figures S5, S4, S9, and S12.
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The Mechanism of Aurilide-Induced Cell Deathcells overexpressing wild-type OPA1 (Figure 5B). These results
supported the hypothesis that the enhanced OPA1 processing
initiates aurilide-induced apoptosis.
Our results suggest that aurilide stimulates OPA1 processing,
ultimately leading to mitochondrial fragmentation and apoptotic
cell death. Recent studies indicate that the OPA1 processing in
mitochondria plays important roles in various biological func-
tions of mitochondria (Westermann, 2002). It has been proposed
that the OPA1 processing activates mitochondrial cristae re-
modeling as well as mitochondrial fragmentation, leading to
cytochrome-c release and cell death (Cipolat et al., 2006; Frezza
et al., 2006). Prolonged fragmentation of mitochondria has also
been reported to be a trigger for loss of membrane potential in
HeLa cells (Olichon et al., 2003), eventually leading to apoptotic
cell death (Olichon et al., 2003; Yang et al., 2001).
We monitored mitochondrial membrane potential in the cells
treated with aurilide for 0, 4, and 16 hr by using JC-1, a fluores-
cent indicator of membrane potential (Figure 4C). The aggrega-134 Chemistry & Biology 18, 131–139, January 28, 2011 ª2011 Elsevier Ltd All rights rtion pattern of JC-1 and its color changes
indicated that prolonged treatment of cells
with aurilide for 16 hr lowered mitochondrial
membrane potential in the treated HeLa cells
during the course of cell death, whereas 4 hr of
treatment or treatment with DMSO had no
significant effects on membrane potential.
Quantitative analysis by FACS (Figure S6) re-
vealed that 16 hr of incubation with aurilide
lowered membrane potential in 60% of the
treated cells, whereas 4 hr of incubation with
aurilide or 16 hr of incubation with DMSO alone
exhibited only 7.9% or 1.9%. Taken together,
our results suggest that aurilide induces pro-
longed mitochondrial fragmentation through
enhanced OPA1 processing, which results in
loss of membrane potential and induction of
apoptotic cell death.
During our studies, an independent research
group recently reported a role of prohibitinin regulating OPA1-dependent cristae morphogenesis and
apoptosis in mitochondria (Merkwirth et al., 2008). In this report,
knockdown of prohibitin indeed induced the OPA1 processing.
Our identification of PHB1 as a target protein of aurilide provides
chemical genetic evidence in support of this newly discovered
role of PHB1 in the OPA1 processing. The remaining question
is how the inactivation of PHB1, either by siRNA knockdown or
aurilide, activates the OPA1 processing. One possible explana-
tion is that membrane-bound PHB1 might directly regulate the
processing or localization of OPA1 by binding with each other.
This possibility is unlikely because we failed to detect such inter-
action in a coimmunoprecipitation experiment (Figure 6).
Another possibility is that OPA1-processing proteases might
be sequestered by membrane-bound PHB1 and released by
the PHB1-aurilide interaction. In yeast, the protease that specif-
ically processes the yeast homolog of OPA1, Mgm1, has been
identified to be them-AAA protease, a hetero-oligomeric proteo-
lytic complex in the mitochondrial inner membrane. Although theeserved
Figure 4. Effects of Aurilide on the Mito-
chondrial Morphology and Apoptosis
Induction in HeLa Cells
(A) Mitochondrial fragmentation was observed 4 hr
after aurilide treatment, but any apoptotic pheno-
types including nuclear condensation and round
cell shapes were undetectable.
(B) Effects of aurilide on the PARP cleavage. After
4 hr of treatment with aurilide, when the mitochon-
drial fragmentation is observed, we failed to detect
an 85-kDa-breakdown product of PARP. The
breakdown product became apparent after 16 hr
of treatment with aurilide.
(C) Effects of aurilide on mitochondrial potential in
HeLa cells. HeLa cells were treated with aurilide
(100 nM) or DMSO alone (1% [v/v]), and stained
by JC-1. Most of the DMSO-treated cells had
strong J-aggregates (red). In contrast, aurilide-
treated cells exhibited only green fluorescence
due to lowered mitochondrial membrane potential
after 16 hr.
See also Figures S6, S7, and S8.
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The Mechanism of Aurilide-Induced Cell Deathhuman homolog of them-AAA proteasemay partially be involved
in the processing of OPA1 (Ishihara et al., 2006), the identity of
such an OPA1-processing protease in mammalian cells has
been elusive, making it difficult to test this mechanistic hypoth-
esis in human cells.
Aprevious report suggests that theactivityof theyeasthomolog
of m-AAA protease interacts with and is negatively regulated by
yeast prohibitin inmitochondria (Steglich et al., 1999). To examine
whether the human m-AAA protease, which is composed of
multiple ATP-dependent proteases such as spastic paraplegia 7
(SPG7), binds to PHB1, we performed coimmunoprecipitationChemistry & Biology 18, 131–139, January 28, 2011experiments using FLAG-tagged PHB1.
The results showed that spastic para-
plegia 7 (SPG7), a component of the
humanm-AAA protease, was coimmuno-
precipitated with FLAG-tagged PHB1 as
well as endogenous PHB1 and PHB2.
Treatment with aurilide reduced the inter-
action of PHB1 with SPG7, whereas
aurilide had no detectable effects on the
PHB1-PHB2 interaction (Figure 6; Fig-
ure S10), suggesting that aurilide selec-
tively disrupts the PHB1-m-AAA protease
interaction. Nevertheless, it is unlikely that
the release of the humanm-AAA protease
from the membrane-bound PHB1-PHB2
complex is the sole factor that drives the
aurilide-induced OPA1 processing. In
fact, siRNA knockdown of the m-AAA
protease in human cells by others and us
had limited effects on the OPA1 process-
ing (Wu et al., 2007). Other as-yet-unrec-
ognized proteases may also bind to
PHB1 and participate in the aurilide-
induced OPA1 processing. Aurilide may
be useful in isolating and identifying these
proteases in future studies.Another protein that influences OPA1 processing has recently
been found to be the mitochondrial rhomboid protein PARL (Ci-
polat et al., 2006). However, the relationship of PARL with PHB1
in regulating OPA1 has not been addressed. PARL and PHB1
may play separate roles in controlling OPA1 processing,
because our immunoprecipitation experiments failed to detect
any physical interactions between PHB1 and PARL (data not
shown). Further studies are needed to clarify this issue. A search
for proapoptotic and antiapoptotic factors relevant to PHB1 is
currently underway, and aurilidemay serve as a pharmacological
probe for studies of mitochondria-induced apoptosis.ª2011 Elsevier Ltd All rights reserved 135
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Figure 5. Activation of OPA1 Processing by Aurilide
(A) Western blot analysis of endogenous OPA1, PHB1, PHB2, Mfn1, and actin
proteins after treatment with aurilide. Treatment of cells with aurilide (100 nM)
for 16 hr stimulated the processing of OPA1 from large isoforms to short
isoforms; the other proteins tested exhibited no detectable effects.
(B) Overexpression of a processing-resistant OPA1 protein rendered cells
resistant to aurilide. The full-length OPA1 and OPA1-DS1 variant 1 were
overexpressed in HeLa cells. The processing site is indicated in yellow, and
the numbers represent amino-acid residues of OPA1 (upper panel) and
OPA1-DS1 (lower panel). The HeLa cells and controls were treated with
6 nM of aurilide. The cell survival data are means ± SD for a minimum of three
experiments. Expression of OPA1-DS1 rescued the cells from the aurilide-
induced cell death; expression of full-length OPA1 (Full) had little effect.
Aurilide (1)DMSO10%input
SPG7
OPA1
FLAG-PHB1
PHB1
PHB2
Figure 6. Coimmunoprecipitation Experiments of FLAG-Tagged
PHB1
HeLa cells stably expressing FLAG-tagged PHB1 were treated with aurilide
(100 nM) or DMSO alone (1% [v/v]) for 16 hr, and their membrane extracts
from the cells were then prepared for immunoprecipitation with anti-FLAG
antibody. Immunoprecipitated samples and the input sample were resolved
by 10% SDS-PAGE and were analyzed by western blotting with the anti-
Myc, anti-OPA1, anti-PHB1, or anti-PHB2 antibodies. For the analyses of
SPG7, the HeLa cells stably expressing FLAG-tagged PHB1 were transiently
transfected with an expression vector of Myc-tagged SPG7 (pCMV-SPG7),
and their membrane extracts were used for immunoprecipitation. Immunopre-
cipitated proteins are indicated by arrowheads. Treatment with aurilide
reduced the interaction of PHB1 with Myc-tagged SPG7, whereas aurilide
had no detectable effects on the PHB1-PHB2 interaction. OPA1 exhibited
no detectable interaction with prohibitin.
See also Figure S10.
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The Mechanism of Aurilide-Induced Cell DeathPHB1 has been reported to be overexpressed in 84% of
bladder cancers (Wu et al., 2007), and its mutations have been
implicated in breast cancers (Sato et al., 1993). Our results indi-
cate that aurilide induces apoptosis by inhibiting the function of
this cancer-related protein, unlike other known antiproliferative
and proapoptotic molecules. Naturally occurring aurilide
analogs, kulokekahilides (Kimura et al., 2002; Nakao et al.,
2004) and aurilides B and C (Han et al., 2006), have recently
been isolated from other marine organisms. These highly
cytotoxic analogs are also likely to exert their proapoptotic
activity through the inhibition of PHB1. Aurilide and its analogs
may ultimately prove to be candidates for further evaluation as
anticancer drug leads.SIGNIFICANCE
One way to use bioactive small molecules for biological
investigation is to identify their protein targets, although
target identification has always been a technical hurdle in
the field. In this study, we isolated a target protein of aurilide,
a cytotoxic marine natural product. Biochemical and molec-
ular biological experiments revealed that the interaction of
aurilide with PHB1 activates the proteolytic processing of
OPA1, which has been shown to play a central role in mito-
chondria-induced apoptosis. Aurilide represents the first
small molecule that inhibits the function of prohibitin in the
regulation of OPA1 and mitochondria-induced apoptosis.
The molecular biology of OPA1 and mitochondrial remodel-
ing has recently become a target of intensive research in the136 Chemistry & Biology 18, 131–139, January 28, 2011 ª2011 Elsevfield of apoptosis (Cipolat et al., 2006; Frezza et al., 2006).
Aurilide may serve as a chemical tool to investigate the
prohibitin-mediated regulation of apoptosis.
EXPERIMENTAL PROCEDURES
Materials
Human HeLa cells were maintained in DMEM supplemented with 10% fetal
bovine serum at 37C under humidified 5% CO2. Conjugates 3–6 were
chemically synthesized either on a solid support or in a solution, and purified
by a reverse-phase HPLC as described in the Supplemental Experimental
Procedures.
Antibodies
The following primary antibodies were used: anti-PHB1 and anti-PARP
(Cell Signaling Technology), anti-PHB2 (Upstate Biotechnology), anti-OPA1
(BD Bioscience), anti-MFN1 (Novus Biologicals), anti-cytochrome c and
anti-FLAG (Sigma Chemical Co.), and anti-actin (Santa Cruz).
Synthesis of 3 and 4
A polyproline linker was synthesized on Rink-Amide MBHA resin (0.6 mmol/g,
Nova Biochem) by coupling N-a-Fmoc-protected amino acids (Nova
Biochem), N-3-Fmoc-3-aminocaproic acid (Nova Biochem), and D-biotin
(Sigma-Aldrich), purified by a reversed phase HPLC, and characterized by
mass spectrometry. The linker was then coupled with the active ester (succi-
nate) of molecule 1 or 2 (Figure S11). After removal of protective groups by
2% (v/v) hydrazine treatment, conjugates 3 and 4 were purified by a
reversed-phase HPLC and were characterized by mass spectrometry.
For the polyproline linker, calcd for C79H128N19O15S
+ requires 3412.2
(found [MALDI-TOF-MS] 3434.0 [M+Na]+). For conjugate 3, calcd forier Ltd All rights reserved
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The Mechanism of Aurilide-Induced Cell DeathC79H128N19O15S
+ requires 3784.7 (found [MALDI-TOF-MS] 3785.3 [M+H]+).
For conjugate 4, calcd for C53H79ClN11O9S
+ requires 3784.7 (found
[MALDI-TOF-MS] 3784.6 [M+H]+).Synthesis of 5 and 6
To a solution of molecule 1 (9.3 mg, 0.009 mmol) and triethylamine
(0.011 mmol) in DCM-DMF, we added mono-Fmoc 1,6-diaminohexane
hydrochloride (0.011 mmol), HOBt (0.013 mmol), and 1-Ethyl-3-(3-dimethylla-
minopropyl) carbodiimide hydrochloride (0.027 mmol) at 0C. This solution
was stirred at room temperature overnight, diluted with CHCl3, washed with
HCl (0.01 N), saturated with NaHCO3 and brine, and dried over anhydrous
Na2SO4. The combined extract was concentrated in vacuo, and the residue
was purified by column chromatography on silica gel with CHCl3-methanol
mixtures to give the Fmoc-amino hexanamide derivative of aurilide (11.7 mg,
97%). The Fmoc group of the conjugate was then removed by 20% piperidine
in DMF, and the deprotected sample was purified by column chromatography
on silica gel with CHCl3-methanol (4:1) and coupled with FITC (0.021 mmol) in
the presence of triethylamine (0.086 mmol) at room temperature for 20 hr. The
reaction mixture was concentrated in vacuo, and the residue was purified by
a column chromatography on silica gel with CHCl3-methanol mixtures to
give conjugate 5 (Figure S12). Further purification was performed by HPLC
for biological assay. The corresponding 6-epi-aurilide conjugate 6 was
similarly synthesized from molecule 2 (Figure S12).Target Identification of Aurilide Using Affinity Matrix
Nuclear extracts were prepared as described elsewhere (Meisterernst
and Roeder, 1991). Cytosolic extracts were obtained by disrupting the cell
membrane with a French press in PBS and by centrifuging the sample to
remove the cell debris. The removed insoluble cell debris was suspended in
PBS containing 0.1% Nonidet-P40, and the solubilized fraction was used
as membrane extracts. Each of the extracts prepared from an 8-L culture
was incubated with slurry of Neutravidine-agarose beads (1 ml) saturated
with biotin conjugates 3 or 4 on ice for 24 hr. After an extensive wash
with PBS, the beads were treated with 6His-tagged HRV-3C protease
(30 units/ml) in PBS at 4C for 16 hr. The sample was then filtered with an
empty polypropylene chromatography column (Biorad). After removal of the
protease by 100 ml of His-Bind resin (Novagen), proteins in the flow-through
were separated by SDS-PAGE. The 32-kDa band specific to conjugate 3
was excised from the gel and subjected to in-gel digestion using trypsin.
The resulting tryptic peptides are extracted and subjected to LC-MS/MS
analysis.Overexpression and Knockdown of PHB1
For the generation of the cell lines in which PHB1 is overexpressed or knock
downed, pcDNA3.1His(B) or pSuper-siRNA expression vector of PHB1 were
transfected into HeLa cells using Lipofectamine 2000 reagent (Invitrogen).
Stable transfectants were selected by G418. Expression levels of PHB1
were estimated by western blot analysis using an antibody for human PHB1.Mutant Production of OPA1
The OPA1-deletion mutant (D190-200; variant 1-DS1) was created from the
wild-type construct by overlap PCR. The primers for the mutation were as
follows (underlines indicate the site of mutation): N-termOPA1m, 50-CAC
CTT TCT AAA ATG CTT GTC ACT TTC TTC CGG AGA ACC TGA GGT AAA
AAA GTC CTT C-30; and C-termOPA1m, 50-CCT CAG GTT CTC CGG AAG
AAA GTG ACA AGC ATT TTA GAA AGG TGT CAG AC-30 OPA1fwd and
OPA1rev. The first amplified PCR product was used as a template of the
second PCR. The second amplified PCR product was cloned into the
pCMV-3Tag-3 vector (Stratagene) and fully sequenced.Cytotoxicity Assay
Aurilide was dissolved in DMSO before being diluted to its working concentra-
tions in a culture medium. HeLa cells were seeded at 2000 cells per well in
96-well plates, and aurilide was added on day 2. Three days after the aurilide
addition, cell viability was evaluated by using WST-1 reagent.Chemistry & Biology 18, 131Immunoprecipitation
The HeLa cells overexpressing FLAG-tagged PHB1 were treated with aurilide
(100 nM) or DMSO alone (1% [v/v]) for 16 hr, and then homogenized with
a Dounce homogenizer in buffer A (a 10-mM HEPES buffer containing
1.5 mMMgCl2, 10 mM KCl, and 0.5 mM DTT). Soluble fractions were removed
by centrifugation, and the remaining samples were extracted with PBS
containing 0.1% NP-40 by using a Dounce homogenizer on ice. The
membrane extract was centrifuged at 4C for 60 min at 15,000g, and the
supernatant was filtrated. For immunoprecipitation, the filtered sample was
incubated with M2-agarose beads (Sigma Chemical Co.) at 4C for overnight.
Bound fractions were eluted by SDS-PAGE sample buffer, separated by
SDS-PAGE, and blotted onto a nitrocellulose membrane for western analyses.
For the analyses of SPG7, the HeLa cells stably expressing FLAG-tagged
PHB1 were transiently transfected with an expression vector of Myc-tagged
SPG7 (pCMV-SPG7), and their membrane extracts were used for immunopre-
cipitation. pCMV-SPG7 was constructed by inserting a cDNA of SPG7 into the
pCMV-3Tag-9 vector (Stratagene) and was fully sequenced. The primers used
for the cloning of the SPG7 cDNA were as follows: N-termPara, 50-AAG GAA
AAA AGC GGC CGC CAC CAT GGC CGT GCT GCT GCT GCT GCT CCG
TGC CCT GCG-30; and C-termPara, 50-GAT CCT CGA GCT TGG GCC AAG
TCG GCT CTT CGC CTC CAA GTG GAG GC-30.
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